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The essential role of Factor VIII:C (FVIIK, anti-hemophilia f ctor A) as a cofactor for Factor IX,-dcpendcnt activation of Factor X has been 
established. in this paper. we describe that capillary endothelial cells from bovine adrenal medulla express active FVLII:C gene. Accutnulation of 
FVIII:C in conditioutd me dia from an S-day-old culture is approximately twice as hi& as that stored in the cell when immunoprecipitated FVIII:C 
was analyzed for its ability to convert Factor X iO Factor X,. Analysis of [“S]mcthioninc-labeled and immunoprecipitated FVIII:C from cells or 
conditioned media on SDS-PAGE under fully denatured conditions indicated that the newly synthesized FVlII:C consists of heavy chain of M, 
200.000 and light chain of llf, 4G,OOO. The secreted FVIII:C in the non-reduced condition howc~cr, has n moleculm wci&t of 270,000 which suggests 
that in native protein, the heavy and light chains are held together by S-S bonds. Furthermore. susceptibility of the immunoprecipitatd FVIIl:C 
to N-glycanasc digestion establishes that the cndothelial cells derived FVIII:C contains asparaginc-linked carbohydr;itc side chains. 
Blood coagulation Btctor VIII:C; Capilliary cndothclial cell; Gene expression; N-linked glycoprotein; Disulphidc bridge; Adrenal medulla 
1. INTRODUCTION 
Factor VIII:C, (FVIII:C) is an essential cofactor for 
Factor IX, dependent activation of Factor X and itself 
can be activated proteolytically by a variety of coagula- 
tion enzymes including thrombin [l]. Its plasma concen- 
tration is extremely low (So-150 ng/ml) and deficiency 
of FVIII:C leads to classic hemophilia (hemophilia A), 
a bleeding disorder that affects lo-20 per 100,000 
males. The disease is transmitted by X-chromosomal 
inheritance f2] in which blood clots slowly, prothrombin 
is converted to thrombin at an abnormally slow rate and 
a rebleeding phenomena is frequently seen. The cloning 
of cDNA and the gene for human plasma Factor VIII:C 
has provided some information about its gene structure 
[3-61. Various sites for the biosynthesis ofFVIII:C have 
been proposed. Reports of liver transplantation i pa- 
tients with hemophilia and end-stage liver disease [7,8] 
have supported the earlier animal studies [9] about the 
role of liver in FVIII:C synthesis. Northern blot analy- 
sis with Factor VIII:C cDNA probes has demonstrated 
that liver, placenta, kidney [3,10], spleen, lymph node, 
pancreas, muscle and fetal heart [l l] contain Factor 
VIII:C mRNA. Several cell types or tissues on the other 
hand appear to lack Factor VIII:C mRNA when exam- 
ined by imrnunochemical methods using light or elec- 
tron microscopy [12,13]. FVIII:C, however, has been 
localized in hepatic sinusoidal endothelium by im- 
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munoperoxidase staining using a monoclonal antibody 
to FVIII:C [14]. 
In the present paper we describe that the capillary 
endothelial cells from bovine adrenal medulla synthe- 
size FVIII:C. It is a constitutivc asparaginc-linked 
glycoprotein which converts Factor X to Factor X, in 
the presence of Factor IX,, phospholipid and Ca3+ and 
is distinct from the von Willebrand Factor (vWF). 
2. MATERIALS AND METHODS 
9.1. Chertticuls 
Monoclonal antibody (IgGlk) to human FVIII:C (lack cross-reac- 
tivity with vWF present in hemophilic plasma) was obtained from 
Boehringcr-Mannhcim. COATEST Faotor VIlI:C assay kit was a 
product of Helena Laboratories. [‘“S]Methioninc and [‘4C]mcthylnlcd 
protein standards were purchased from Amcnham. Immobilon was 
3 gift from Millipore Corporation. vWF Immunoblot was supplied b> 
Ramco Laboratories. Inc. p_Nitrobluc tctraaolium chloride (NBT), 
5.bromo4chloro-3.indolylphosphatc-toluidine salt (BCIP), SDS, 
acrylamidc, bis-acrylamidc, TEMED, Twecn 20 and p-mcrcaptoetha- 
nol wcrc purchased from Bio-Rad Laboratories. Peroxidnse conju- 
gated anti-rabbit mouse ISG was a product of Miles Laboratory, 
3,3’-diaminobcneidinc, PMSF, TPCK, soybean trypsin inhibitor, 
aprotinin, Icupeptin, cyclohcxintide and DTT were obtained from 
Sigma Chemical Co. Acdnomycin D was a product of Colbiochcm. 
Minimal essential medium with Earlc’ssalt (EMEM), glutamine, tryp- 
sin-verscnc and penicillin-streptomycin wcrc supplied by Biofluidss 
Inc. Fetal bovine serum (FCS) was a product of MyClone Laborato- 
ries. Protein A-Scpharosc CL-4B was obtained from Pharmacia. N- 
and O-glycanases were purchased from Genzymc. All other chemicals 
-erc of highest purity grade. 
The stock culture of capillary cndothclial cells was maintained in 
EMEM containing 10% FCS (heat-inactivated), ghrtaminc (2 mM), 
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penicillin (50 units/ml) and streplomycin (SO Pg/ml) and subcultured 
once u week as described before [ 15,16]. Cel!s with 80-998 confluency 
were used in this study. 
2.3. I\~LJUSIIIYII!~,~ oJ F WI: C nrtiqv in aldotl~ciihl cell lpm 
The generation of activated Factor X by Factor IX,, is greatly 
stimulutcd by FVIIl:C which is considered as a cofactor in this reac- 
tion [17-191, The assay is designed to give u linear correlation between 
the amoun[ of generated Factor X, and the FVItI:C content [20]. 
Factor X, is then determined by mcusurinp thercleaseofp-nitroanilinc 
from a chromogenic substrate. In a typical bioussny (COATEST 
Assay), immunoprecipitated FVlII:C from different samples were 
used for acid-stopped method as described in ihc supplier’s manual. 
2.4. Biox~ttriwsis of Fncrur IWi:C 
The cells were cultured for 8 days in complete EMEM, washed with 
methionineJrcc and serum-free media and labclled with [“‘Slmcthion- 
inc (30-4OpCilml) in methionine-free and serum-free medium contain- 
ing I pghil ofnprotinin at 37°C. At an appropriate lime the medium 
was removed, and the cells were lysed. Aliquots of conditioned media 
and cell extracts were immunoprecipitated with 1 mouse monoclonal 
antibody to FVIIK (I:40 dilution) for 3 h at 4°C followed by I2 h 
with 50 rug/ml of Protein A-Sepharose CL-48 (30 mdml) in the pres- 
cnce of PMSF (I mM), TPCK (?OOgM), soybean trypsin inhibitor (I 
p&ml) and leupeptin (I PM), The Protein A-Sepharorcxnligcn-anti- 
body complexes were washed twice with NET buffer, twice with wash- 
ing buffer, and once with PBS, pH 7.4. The immunccomplcxes were 
then unalyzed by SDS-PAGE (7.5 or 10%) followed by autorodiogra- 
phy. For non-xeducing gels, @.mercaptoethanol was omitted from the 
sample buffer as well as from the washing buffer. To study the effect 
of actinomycin D or cycloheximide, the cells were prcincubated with 
actinomycin D (2 ,@ml) or cycloheximidc (I p&ml) for I h at 37°C. 
The rest of the procedure was the same as described above. 
2.5. N- ur~rl O-gl~rur~asc dig&m of Fuctw VifI:C 
The immunoprecipitated samples were suspended in 5Oyl of20 mM 
sodium citrate, boiled for 5 min and then incubated with N-glycanase 
(5 U/ml) for 2 h [21], For U-glycanase digestion, the immunoprecipi- 
tatcd FVIII:C samples were solubilized in Tris-Buiicr (0.01 M Tris- 
I-ICI, pH 7.4, 0.15 M N&I, 1% NP-40, 0.025% SDS, 0.25% DIT, 5 
mM EDTA) and then incubated with 100 mu/ml of O-glycanasc at 
37°C for 24 h in a total volume of 55 ~1 [?I]. The samples wcrc then 
prepared for SDS-PAGE as described above. 
The proteins in cell lysatc and conditioned media wcrc separated on 
10% SDS-PAGEaccording to lbe procedure of Laemmli [22] and then 
transferred to Immobilon at 70 V for I8 h in Tris-glycine buffer system 
123.241. After electrotransfer and blocking, the membrane was incu- 
bated with alkaline phosphatase-conjugated nti-von Willebrand Fuc- 
tor antibody (I:500 dilution) for 2 h at room temperature. The bloi 
was then washed and the color was developed with NBT and BCIP. 
3. RESULTS AND DISCUSSION 
F VIII: C 
To support the observation that these endothelial 
cells are synthesizing FVIII:C in active form, im- 
munoprecipitated FVIII:C from the cell lysatc as well 
as from the conditioned media were subjected to a chro- 
mogenic assay where the conversion of Factor X to 
Factor X, has been quantitated by measuring the prote- 
olytic release ofp-nitroaniline bound to a synthetic pep- 
tide (S-2222). The release ofp-nitroaniline was quantita- 
tive and dependent upon the amount of the cell lysate 
34 
Fig. 1. Measurement of FVIII:C activity. Samples from cell lysnt;, 
conditioned media, bovine plasma nd human plasma were immuno- 
precipitated with anti-FVIll:C antibody as described in section 2 and 
assuyed for FVIIK-dependent Factor X, generation by measuring 
p-nilroaniiinc spectrophotometrically t 405 nm. I, cell lysate (2OOpl): 
2, conditioned media (200 ~1); 3. livsh bovine plasma (20 ~1); 4, stored 
human plasma (20 yl); S, cell culture media containing 10% fete1 
bovine serum (200 yl); 6, cell lysate containing 1 k&ml of aprotinin 
(200 ,Lll). 
or conditioned media present in the assay. The results 
as summarized in Fig. 1 indicated that both cell lysate 
and the conditioned media contained active FVIII:C 
(lanes 1 and 2). Factor X, dependent generation of p- 
nitroaniline, however was twice as high in the condi- 
tioned media as in the cell @ate. Both human and 
bovine plasma controls also showed lo- to 30-fold 
higher activity (lanes 3 and 4). Since, the release of 
p-nitroaniline from the chromogenic substrate (S-2222) 
is a proteolytic cleavage, therefore, collection of cell 
lysate or conditioned media in the presence of aprotinin, 
a protease inhibitor completely inhibited the FVIII:C 
dependent Factor X:, activity (lane 6). In addition, since 
the culture media contained 10% fetal bovine serum, 
therefore, quantitation of serum borne FVIII:C in the 
cell culture media indicated the presence of only 1110th 
of what has been observed in the conditioned media [S]. 
The monoclonal antibody used here is speciiic for 
FVIII:C and hence, non-interference of FVIII:C de- 
pendent Factor X, production by the immunecom- 
plexes helped in using a cleaner preparation free from 
contaminating proteases. This is possible only because 
of antibody recognition site is different from its catalytic 
site. In addition, use of a complete reaction mixture 
minus FVIll:C immunoprecipitate as a blank elimi- 
nated the possibility of tissue factor/Factor VII as pos- 
sible contaminants in these preparations. Furthermore, 
increased level of FVIII:C in the conditioned media 
ruled out cellular acquisition of Factor VIII:C from the 
serum present in the culture media. 
3.2. De-novo synthesis of PVIII:C in the cupillary ertdo- 
thelirrl ccl/s 
In order to demonstrate that FVIII:C is indeed made 
























Fig. 2. Synthesis of FVlII:C in capillary endothelial cells. Cells were grown for eight days in GO mm dish and lab&d with [35S]methionine(30~Ci/ml. 
sp.act. 1400 Wmmol) for 2 h at 37OC as described in section 2. Equal aliquots from each sample were analyzed on SDS-PAGE after immunoprc- 
cipitation with anti-Fnctor VIII:C antibody. (a) Dctcction of Factor VIIl:C before and after immunoprccipitation against anti-Factor VIlI:C 
antibody on 7.5% SDS-PAGE under reduced condition; lane A. before immunoprccipitation; lane 6. after immunoprecipitation. (b) Migration 
of FVIlI:C on SDS-PAGE under reduced (larlrs 1 and 2) and non-reduced (lanes 3 and 4) conditions; Ianc 1. cell lysatu; lane 2, conditioned media; 
lane 3, cell lysate; lane 4, conditioned media. (c) Effect of actinomycin D and cyclohcximidc on FVIll:C biosynthesis. The cells were treated with 
actinomycin D (2 /@ml) or cyclohcximide (1 &/ml) and then labclld with [“‘S]mcthionine (30 /@ml, sp.act. 1400 CiImmol) as described in section 
2. The immunoprecipitates were then analyzed on a 10% SDS-PAGE. Lane 1, control; lane 2, actinomycin D; lane 3, cycloheximidc. 
by these cells, the cells were labelled with [35S]methio- 
nine. The labelled proteins when analyzed by SDS- 
PAGE under reduced condition followed by autoradi- 
ography showed the presence of a number of protein 
species ranging from M, 200,000 to M, 15,000. After 
immunoprecipitation with mouse monoclonal antibody 
to FVIII:C only M, 200,000 and M, 46,000 species were 
detected (Fig. 2a, lanes A and B). A somewhat diffuse 
band close to M, 14,300 in lane I3 and right at the dye 
front has been noted whose relationship to M, 200,000 
and M, 46,000 has not yet been understood except hat 
it is recognized by the antibody. To investigate the shx 
of FVIII:C further, the immunoprecipitates were sub- 
jetted to SDS-PAGE under both reducing and non- 
35 
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69,000- 
46,000- 
Fig. 3. N- and O-glycnnase digestion of secreted FVlII:C. Cells were 
cultured for eight days in 60 mm dishes, lnbelled with [%]methioninc 
(30,uCi/ml, sp.act. 1400 Wmmol) for 2 h at 37% and the conditioned 
media was immunoprccipitated with anti-FYIII:C antibody as above. 
The immunoprecipitates were then digested with N-and O-glycanases. 
- enzyme, control; +I?-gly, digested with N-glycanase; +o-gly, digested 
with U-glycanasc. 
reducing conditions. Under fully reduced condition, 
heavy chain of M, 200,000 and light chain of M, 46,000 
were present in cell lysate (Fig. 2b, lane 1). A minor 
band just below the M, 200,000 band has been seen 
particularly in this preparation which is most likely gen- 
erated either by a mild proteolysis or by incomplete 
processing. The molecular weight of the heavy chain 
was slightly higher (i.e. M, 215,000) in the conditioned 
media (Fig. 2b, lane 2). On the other hand, under non- 
reduced condition though no changes in the molecular 
weight for cellular components were observed, a protein 
of M, 270,000 appeared in the conditioned media in 
addition of the M, 215,000 species (Fig. 2b, lane 4). This 
implied not only the existence of FVlII:C gene in these 
cells but also the heavy and light chains in the secreted 
FVIII:C are held together by S-S bond. When the ques- 
tion on the existence of FVIIIC gene was answered by 
radiolabelling of cells in the presence of actinomycin D 
(2 ,uuglml), it demonstrated reduced %-methionine in-
corporation into FVIII:C whereas cycloheximide (1 pg/ 
ml) completely abolished it (Fig. 2c, lanes a-c). 
These observations then provide evidence that capil- 
lary ecdothelial cells arc indeed one of the site(s) for 
Factor VIII:C biosynthesis. Reduction of [%]methio- 
nine labelled FVIII:C in actinomycin D-treated cells as 
well as its near absence in the presence of cycloheximide 
further supported the presence of active trknscribable 
FVTII:C gene in these cells. Deduced amino acid se- 
quence from the DNA sequence speculated that the 
protein core for FVIII:C is 270,000 Da and if fully 
glycosylated then it could acquire a mol.wt. of M, 
330,000. However, a protein of this size has not yet been 
documented. In any event, if this is found to be true then 
endothelial cell derived FVIII:C has a molecular mass 
between that of human and porcine plasma (M, 
240,000) [25]. Furthermore, the presence of S-S bond 
in endothclial cells derived FVIII:C put the earlier claim 
of Ca” bridge in porcine plasma FVIII:C in a question- 
able doubt [25]. 
3.3. Susceptibility of FVIII:C to N-gtycanase digestion 
Many plasma proteins are known to carry carbohy- 
drate r&dues bound to the protein core. After deter- 
mining that these endothelial cells possess glycosylating 
activity for the asparagine-linked (N-linked) glycopro- 
teins [163, we became interested in studying the protein- 
carbohydrate linkage in FVIII:C. When the im- 
munoprecipitated FVIII:C from conditioned media was 
digested with N- and O-glycanases, we observed that it 
became susceptible to N-glycanase digestion but not to 
O-glycanase (Fig. 3). This indicated that FVIII:C is 
indeed an asparagine-linked glycoprotein. Reduction in 
molecular weight of the light chain by -5,000 Da (i.e. 
M, 46,000 to M, 38,000) indicated that the light chain 
contains 17% carbohydrate and hence IC, rich in carbo- 
hydrates, This certainly supports the earlier observation 
that light chain of recombinant FVIfI:C is also rich in 
carbohydrate [27]. 
3.4. Detection of volt Wiilebrand Fucror 
Immunocytochemical analysis with a polyclonal anti- 
body to human FVIII-associated antigen (FVIII:AR) 
detected the presence of Factor VIII in these cells [lS]. 
Since, FVIII:C circulates as a complex with von Wil- 
lebrand Factor (vWF) in the plasma, it was then ques- 
tioned whether vWF was similarly synthesized in these 
cells. Consequently, we have analyzed the cell lysate and 
the conditioned media by Western blotting using alka- 
line phosphatase-conjugated polyclonal antibody to 
human vWF raised in rabbit. The results (data not 
shown) indicated that when the blot was treated with 
anti-vWF antibody, the human plasma reacted strongly 
with the antibody and the bovine plasma only weakly, 
whereas the interactions were completely absent in the 
endothelial cell lysate and conditioned media. The poor 
reactivity of the antibody raised against he human pro- 
36 
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tein prevented efinitive demonstration of the absence 
of vWF in these cells. 
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